Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transcutaneous sacral neurostimulation for irritative voiding dysfunction.

I K Walsh1, R S Johnston, P F Keane

  • 1Department of Urology, Belfast City Hospital, Belfast, Northern Ireland/UK.

European Urology
|March 11, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Daily, monthly and seasonal variation in PSA levels and the association with weather parameters.

Prostate cancer and prostatic diseases·2010
Same author

Splenogonadal fusion: an interesting differential for a testicular lump.

Irish journal of medical science·2010
Same author

Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?

Prostate cancer and prostatic diseases·2008
Same author

Efficacy and safety peri-prostatic local anaesthetic injection in trans-rectal biopsy of the prostrate: a prospective randomised study.

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·2004
Same author

Sequential polyurethane-poly(methylmethacrylate) interpenetrating polymer networks as ureteral biomaterials: mechanical properties and comparative resistance to urinary encrustation.

Journal of materials science. Materials in medicine·2004
Same author

Intra-testicular varicocele presenting as acute scrotum.

Scandinavian journal of urology and nephrology·2004
Same journal

Re: Ultra-hypofractionated Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: 5-year Outcomes from a Pooled Analysis of the FASTRACK Trials.

European urology·2026
Same journal

Re: Alexander D. Sherry, Van To, Criselle D'souza, et al. Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.024.

European urology·2026
Same journal

Re: Hormone Therapy Use and Duration with Postoperative Radiotherapy for Recurrent Prostate Cancer: an Individual Patient Data Meta-analysis.

European urology·2026
Same journal

Re: Nguyen DD, Tadayon Najafabadi B, Lin L, et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.005.

European urology·2026
Same journal

Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications.

European urology·2026
Same journal

Re: Fecal Microbiota Transplantation plus Immunotherapy in Metastatic Renal Cell Carcinoma: The Phase 1 PERFORM Trial.

European urology·2026
See all related articles

Transcutaneous electrical stimulation of the third sacral nerve effectively reduced symptoms in patients with refractory irritative voiding dysfunction. Patients can self-administer this treatment for potential long-term relief.

Area of Science:

  • Urology
  • Neurology
  • Medical Devices

Background:

  • Irritative voiding dysfunction often presents treatment resistance.
  • Standard therapies may fail to alleviate symptoms effectively.

Purpose of the Study:

  • To assess the efficacy of transcutaneous electrical stimulation of the third sacral nerve.
  • To evaluate this noninvasive method for refractory irritative voiding dysfunction.

Main Methods:

  • 32 patients with refractory irritative voiding dysfunction received ambulatory transcutaneous electrical neurostimulation.
  • Stimulation was applied bilaterally to the third sacral dermatomes for one week.
  • Symptom scores for frequency, nocturia, urgency, and bladder pain were tracked for up to six months.

Related Experiment Videos

Main Results:

  • Daytime frequency decreased significantly (p=0.01) and nocturia episodes were reduced (p=0.01).
  • Urgency and bladder pain symptom scores also showed significant reductions.
  • While 40% experienced symptom recurrence within two weeks and 100% within six months after stopping therapy, three patients maintained satisfaction with continued neurostimulation.

Conclusions:

  • Transcutaneous third sacral nerve stimulation is a potentially effective, noninvasive ambulatory treatment for refractory irritative voiding dysfunction.
  • Self-administration of this therapy may provide long-term symptom relief following an initial positive response.